- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00828100
Comparison of Fluid Rapid Influenza and BinaxNOW Influenza A & B
Comparison of fluID Rapid Influenza and BinaxNOW® Influenza A & B
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The primary objective of this study is to compare the performance of the investigational fluID Rapid Influenza Test and the BinaxNOW® Influenza A & B Test in detecting influenza type A and influenza type B, with respect to fresh nasal wash / aspirate specimens collected from patients presenting with signs and symptoms of influenza-like illness (ILI). Specimens to be evaluated in this study will be enrolled in a concurrent clinical study per protocol FLU-05, entitled "Prospective Evaluation of the fluID Rapid Influenza Test". All subjects enrolled in the FLU-05 study will have consented to having their samples used in future investigations involving the fluID Test.
This study will be conducted during the 2008-2009 influenza season in North America and Hong Kong, which is anticipated to run from November 2008 to May 2009. Should the influenza season conclude in North America and Hong Kong prior to the attainment of the minimum target enrollment specified in the FLU-05 study, study sites in Australia will also be enlisted in order to enroll subjects; in such a case, enrollment will continue during the 2009 influenza season in these countries, which is anticipated to run from May through October, 2009.
Study Type
Enrollment (Anticipated)
Phase
- Phase 3
Contacts and Locations
Study Locations
-
-
Louisiana
-
Shreveport, Louisiana, United States, 71103
- Louisiana State University Health Sciences Center
-
-
Wisconsin
-
Milwaukee, Wisconsin, United States, 53226
- Medical College of Wisconsin
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Male or female subjects of any age;
Subjects presenting to the investigative site within 4 days of symptom onset, with:
- Fever ≥ 38.0°C (100.4°F) if taken orally, or ≥ 38.5°C (101.2°F) if taken rectally; or a self-reported history of fever or feeling feverish (includes fever controlled by medication) in the absence of documented fever;
- One or more respiratory symptoms of influenza-like illness which may include the following:
- Sore throat
- Runny or stuffy nose
- Cough
- One or more constitutional symptoms of influenza-like illness which may include the following:
- Myalgia (aches and pains)
- Headache
- Fatigue
- Subjects (or parent/guardian) willing and able to provide informed consent;
- Subjects must be enrolled in Arm 3 of the FLU-05 clinical study.
Written subject informed consent for this study protocol must be obtained prior to study enrollment. Each subject (or parent or guardian) must personally sign and date the Subject Informed Consent Form prior to his/her participation in this clinical study.
Exclusion Criteria:
- Subjects not presenting with at least three symptoms of influenza-like illness as outlined above.
- Subjects who have received influenza antiviral medication or an investigational influenza drug treatment within the previous 30 days of study enrollment.
- Subjects (children and adults) for whom the obtaining of aspirate samples is contraindicated or not possible.
- Subjects with a medical condition that prevents nasal washes or aspirate samples from being obtained.
- Active duty military personnel (participating military study sites only).
- Subjects (or parent/guardian) unwilling or unable to provide informed consent.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Non-Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Positive percent agreement and negative percent agreement for both influenza A and influenza B.
Time Frame: End of study
|
End of study
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- FLU-13
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Influenza
-
Novartis VaccinesCompletedInfluenza | Seasonal Influenza | Human Influenza | Influenza Due to Unspecified Influenza VirusBelgium
-
Gamaleya Research Institute of Epidemiology and...CompletedInfluenza A | Influenza A Virus Infection | Influenza Epidemic | Influenza H5N1Russian Federation
-
Vanderbilt University Medical CenterHuman Vaccines ProjectCompletedVaccine Reaction | Influenza | Influenza, Human | Influenza A | Influenza Type B | Influenza A H3N2 | Influenza A H1N1United States
-
National Institute of Allergy and Infectious Diseases...CompletedInfluenza Immunisation | Avian InfluenzaUnited States
-
National Institute of Allergy and Infectious Diseases...Completed
-
National Institute of Allergy and Infectious Diseases...Completed
-
National Institute of Allergy and Infectious Diseases...CompletedInfluenza Immunisation | Avian InfluenzaUnited States
-
National Institute of Allergy and Infectious Diseases...CompletedInfluenza | Influenza Immunisation | Avian InfluenzaUnited States
-
National Institute of Allergy and Infectious Diseases...CompletedInfluenza Immunisation | Avian InfluenzaUnited States
-
National Institute of Allergy and Infectious Diseases...National Institutes of Health (NIH)CompletedInfluenza AUnited States
Clinical Trials on fluID Rapid Influenza Test
-
Nanogen, Inc.Centers for Disease Control and PreventionSuspended
-
Catholic University of the Sacred HeartUnknown
-
University of British ColumbiaProvidence Health & Services; Vancouver Airport Authority; WestJet Airlines; KLM...Completed
-
Somerset NHS Foundation TrustUnknown
-
Centre Antoine LacassagneCompleted
-
Pontificia Universidad Catolica de ChileCompleted
-
Salem Anaesthesia Pain ClinicRecruiting
-
Vanderbilt University Medical CenterNational Institute of Mental Health (NIMH)Completed
-
HelixBind, Inc.UnknownCandidemia | BacteremiaUnited States
-
London School of Hygiene and Tropical MedicineHealthNet TPO; Health Protection and Research Organisation; Medical Emergency...CompletedFever | MalariaAfghanistan